Protein synthesis in eukaryotes is regulated by diverse reprogramming mechanisms that expand the coding capacity of individual genes. here, we exploit one such mechanism, termed −1 programmed ribosomal frameshifting (−1 PrF), to engineer ligand-responsive rnA switches that regulate protein expression. First, efficient −1 PrF stimulatory rnA elements were discovered by in vitro selection; then, ligand-responsive switches were constructed by coupling −1 PrF stimulatory elements to rnA aptamers using rational design and directed evolution in Saccharomyces cerevisiae. We demonstrate that −1 PrF switches tightly control the relative stoichiometry of two distinct protein outputs from a single mrnA, exhibiting consistent ligand response across whole populations of cells. Furthermore, −1 PrF switches were applied to build singlemrnA logic gates and an apoptosis module in yeast. together, these results showcase the potential for harnessing translationreprogramming mechanisms for synthetic biology, and they establish −1 PrF switches as powerful rnA tools for controlling protein synthesis in eukaryotes.
The ribosome coordinates the biosynthesis of proteins from mRNA templates according to a standard translational program. While the ribosome typically executes translation uniformly and with high fidelity 1 , in some cases the program is temporarily altered in order to change the protein output of a given gene 2, 3 . This 'reprogramming' endows the translation apparatus with expanded synthetic capabilities, enabling the expression of proteins containing non-canonical amino acids (such as selenocysteine or pyrrolysine) or the regulated expression of multiple distinct protein products from a single mRNA transcript 4 . Some forms of translation reprogramming have been directly adopted for biotechnology, including internal ribosome entry sites (IRES) 5 and co-translational cleaving 2A peptides 6 . Moreover, substantial effort has been directed toward the redefinition of codons to specify unnatural amino acids 7 . While significant progress has been made in these areas, other modes of translation reprogramming remain largely unexplored despite their potential applications to synthetic biology. Many reprogramming mechanisms utilize cis-acting RNA elements embedded within mRNAs. Recently, other RNA-based gene expression frameworks have emerged as powerful tools for engineering biological systems 8 . Over two decades of SELEX and related in vitro selection experiments [9] [10] [11] have yielded synthetic RNA molecules, termed aptamers, that bind to diverse ligands 12, 13 . These aptamers have been coupled to RNA-based expression platforms to construct ligand-controlled gene regulatory tools such as allosteric ribozymes [14] [15] [16] [17] [18] . These RNA devices have been utilized in cellular computation 19 , regulation of gene expression 20 , and phenotypic control 21, 22 . The apparent modularity of device construction suggests that other RNA gene expression frameworks could be exploited to engineer new classes of RNA devices with distinct regulatory opportunities.
We identified −1 programmed ribosomal frameshifting (−1 PRF) as a potentially powerful gene regulatory mechanism for RNA device engineering (Fig. 1) . Eukaryotic −1 PRF signals contained within mRNA transcripts are composed of two principal features: (i) a heptanucleotide slippery site where the frameshift event occurs, with the general sequence X-XXY-YYZ (dashes indicate original frame; X denotes any nucleotide; Y denotes A or U; Z denotes A, C or U); and (ii) a downstream stimulatory RNA structure, typically a hairpin or pseudoknot 23 . When encountering a −1 PRF signal in an mRNA, a fraction of translating ribosomes slip back by a single nucleotide, placing the translation apparatus in the −1 reading frame. This alters the amino acid composition of the polypeptide that is synthesized downstream of the frameshift site.
-1 PRF has been well-studied in retroviruses such as HIV, where it serves to establish a precise ratio of Gag to Gag-Pol proteins 24 . Regardless of variation in mRNA transcript levels or translational activity, the stoichiometry of frameshift to non-frameshift protein products remains constant for a given −1 PRF signal. While viral −1 PRF signals have fixed frameshift activities, it may be possible to engineer frameshift signals to respond to environmental ligands 25 ( Fig. 1a) . Previous studies 26, 27 in vitro and in mammalian cell culture demonstrated the feasibility of small-molecule-regulated −1 PRF using metabolite sensing transcriptional riboswitches that adopt frameshift stimulatory pseudoknot conformations in the presence of their cognate ligands. However, the ligand-binding domains of these bacterial riboswitches are integral components that cannot be exchanged with other ligand-binding RNA aptamer domains and are not easily modified to recognize entirely new ligands. As a result, no general design strategy currently exists for assembling synthetic −1 PRF devices that respond exclusively to an orthogonal small molecule of choice.
Here, we establish a modular platform for engineering ligandresponsive −1 PRF switches and demonstrate the applicability of such devices for gene regulation in vivo. We describe a functional in vitro selection for −1 PRF stimulatory element discovery, bringing together the combinatorial complexity of a classical in vitro RNA selection and the biochemical complexity of a cell lysate. We further leverage rational design and in vivo directed evolution to construct ligand-responsive −1 PRF switches (Fig. 1b) . Our synthetic −1 PRF switches display robust performance as a result of balanced protein output stoichiometry, enabling the assembly of logic gates and a phenotypic control module that responds with precision at the individual cell level.
results

In vitro selection for −1 PrF stimulatory elements
To establish a −1 PRF toolkit for synthetic biology, we set out to compile a collection of active RNA frameshift stimulatory elements that would be suitable for downstream applications. Ideally, these elements should be short in length, have well-defined structures, trigger high efficiency −1 PRF, and be readily exchanged with other frameshift elements of similar size and composition. However, natural −1 PRF stimulatory elements are diverse in both size and sequence 4 and stimulate frameshifting at levels that are tuned for optimal viral replication (typically 5-10%), not maximal efficiency 3 . The above limitations place constraints on the scope of available parts, the modularity for engineering, and the achievable dynamic range of ligand-responsive devices. Therefore, with the intent to generate −1 PRF stimulators optimized for engineering, we developed a selection strategy to discover novel −1 PRF stimulatory elements from large libraries of sequence variants derived from a uniformly compact scaffold.
Our directed evolution discovery approach utilizes mRNA display (Fig. 2a) , a well-established in vitro selection technology 28 . During in vitro translation of mRNA display templates, the amplifiable genotype of the mRNA is linked to the phenotype of the polypeptide through a critical puromycin ligation reaction. While mRNA display is conventionally employed to select for functional proteins and peptides, we repurposed it to select for the translation reprogramming activity of an mRNA 29 (Fig. 2b) . Because of the strong distance dependence of the puromycin reaction 30 , mRNA-peptide fusion occurs only if the ribosome translates the entire mRNA transcript. As a result, upstream stop codons that terminate translation preclude mRNA-peptide fusion formation 31 . We exploited this specificity of puromycin reactivity to differentiate frameshift stimulating sequences from inactive sequences.
An mRNA library was designed such that only active −1 PRF signals form mRNA-peptide fusions and become enriched. Starting from a prokaryotic riboswitch scaffold 26 , 14 of 35 nucleotides were randomized to generate 2.68 × 10 8 sequence variants (Supplementary Fig. 1 ). A library of this size is easily accommodated by the mRNA display technology, which allows for upwards of 10 14 input sequences 30 . To enrich active −1 PRF stimulatory elements, the library was encoded downstream of the heptanucleotide slippery site U-UUA-AAC and an in-frame UAG termination codon. mRNA display templates were translated in vitro in rabbit reticulocyte lysate and purified based solely on the presence of the peptide epitope tags. Unlike traditional mRNA display, which uses the purified mRNA−peptide fusions for subsequent selections, the functional selection for −1 PRF activity is complete at this stage of the cycle.
After three rounds of in vitro selection, assaying of selection products in a dual-fluorescent protein (dual-FP) reporter in S. cerevisiae revealed enrichment for active −1 PRF stimulatory elements with in vivo efficiencies of up to 30% ( Fig. 2c and Supplementary Fig. 2) . Moreover, flow cytometry of individual clones revealed that the ratio of fluorescent proteins remained constant for a given population of cells harboring the same −1 PRF signal, irrespective of total protein synthesis. As a result, two populations of yeast with frameshifting efficiencies that differ by only three-to fourfold are highly resolvable, despite overall expression levels that span several orders of magnitude.
The in vitro selection products were submitted for next-generation sequencing (NGS) to characterize the landscape of frameshift stimulatory elements, with a particular focus on pseudoknot structures (Supplementary Note 1) . A computational pipeline was implemented to identify promising sequence motifs for downstream engineering applications (Fig. 2d) . Sequences were grouped on the basis of compatibility with different hairpintype (H-type) pseudoknot geometries ( Supplementary Fig. 3) , assessed for structure subtype enrichment ( Supplementary  Fig. 4) , and then finally clustered into motifs based on primary sequence identity. The differential abundances of sequence variants within a motif were used to identify nucleotide preferences at variable sites and mutation intolerant positions. This analysis provides strong support for further engineering of −1 PRF motifs, and it forms the basis for rational switch engineering. (b) Methodological approach to build −1 PRF switches. Active frameshift stimulatory elements are discovered from large RNA libraries using a functional in vitro selection. Frameshift stimulatory elements (purple) are then coupled to RNA aptamer modules (gold) by rational design to create frameshift switches. Lastly, frameshift switch devices are optimized by in vivo directed evolution using a frameshift-dependent growth selection. npg rational design and directed evolution of −1 PrF switches To engineer ligand-responsive devices (Fig. 3) , we pursued a modular strategy of rationally coupling −1 PRF signals to smallmolecule-binding RNA aptamers (Fig. 3a) . For the stimulatory element, we chose sequence FS-2 from the in vitro selection. This sequence was the second most abundant sequence in the NGS, it displayed high −1 PRF efficiency in yeast (30%), and it has a confidently predicted pseudoknot fold ( Supplementary  Fig. 5 ). As aptamer domains, we chose the theophylline 12 and neomycin 32 binding aptamers based on their previous successes in in vivo applications 21 .
In the OFF switch design (Fig. 3b) , the RNA aptamer and FS-2 pseudoknot sequences overlap and thus compete for folding. In the absence of ligand, the active pseudoknot predominates and stimulates high −1 PRF activity. However, in the presence of ligand, the folded aptamer is stabilized by ligand binding energy and disrupts the FS-2 pseudoknot, resulting in lowered −1 PRF activity. We designed several constructs by varying the length and composition of the aptamer stems. As a general trend, we found that increasing the thermodynamic stability of the aptamer lowered frameshift activity (Supplementary Fig. 6 ). This simple approach led to the discovery of a high-performing theophylline OFF switch that displays a sevenfold reduction in −1 PRF in the presence of ligand (Fig. 3d , Theo-OFF-3).
Rational optimization of aptamer stability did not result in adequate neomycin OFF switch responsiveness ( Supplementary  Fig. 6 ). Therefore, we devised an in vivo directed evolution platform for optimizing switch performance that exploits the unique output of −1 PRF (Supplementary Fig. 7) . Briefly, −1 PRF devices were inserted between the open reading frames of a Gal4 minimal DNA binding domain (BD) and minimal activation domain (AD) 33 . Overall, expression of Gal4-responsive genes in a yeast two-hybrid strain 34 was a function of the Gal4 (BD) to Gal4 (BD-AD) ratio, which was in turn dictated by −1 PRF efficiency (Supplementary Fig. 8) . We designed a library of neomycin OFF switches and performed selection within the Gal4 npg yeast two-hybrid system, yielding several switches with improved performance (Supplementary Fig. 9 ). The best switch responded to neomycin with a 5.5-fold reduction in −1 PRF (Fig. 3d , Neo-OFF-DE). In addition to directed evolution applications, this Gal4 system could be applicable for small-molecule-regulated transcriptional activation.
To engineer ON switches, a 'switching hairpin' was introduced to compete with FS-2 pseudoknot folding and to reduce basal −1 PRF levels. By design, structural rearrangements stimulated by ligand-aptamer recognition serve to destabilize the switching hairpin, leading to coincident refolding of the pseudoknot and restoration of −1 PRF activity (Fig. 3c) . Several constructs were created to tune the relative stabilities of the ON and OFF states by varying the lengths and compositions of the aptamer stems and switching hairpins. These constructs were assessed using RNA secondary structure prediction (NUPACK) 35 and tested experimentally in the dual-FP assay to correlate hairpin and aptamer stability to switch activity (Supplementary Note 2 and Supplementary Figs. 10 and 11) . With minimal optimization, this approach led to efficient ON switches that respond to theophylline (5.9-fold) or neomycin (4.2-fold) (Fig. 3d , Theo-ON-5 and Neo-ON-4). Notably, for the Theo-ON-5 switch, the population of cells exposed to theophylline is >99% resolved from the population of untreated cells (Fig. 3e) because of the stoichiometrically controlled outputs.
−1 PrF logic gates and phenotypic controllers
We envisioned exploiting translation reading frames by layering −1 PRF devices within individual mRNAs to create logic gates and phenotypic controllers. Logic gates are important genetic devices for executing cellular computation and programming biological systems. While diverse logic gate architectures have been reported 19, 36, 37 , most gates require the expression of multiple components to transduce small-molecule inputs into a gene expression output. We recognized the opportunity to construct highly condensed logic gates from a single mRNA transcript using −1 PRF switches (Fig. 4) .
First, a NOR gate (Fig. 4a) and an AND gate (Fig. 4b) were constructed using fluorescent protein reporters. Predictions of logic gate outputs based on individual switch activities were found to be in good agreement with the experimentally obtained results, demonstrating that the different frameshift switch devices function independently of one another and their context. Moreover, ON and OFF states are well distinguished by flow cytometry, particularly for the NOR gate. Though not demonstrated here, other, more complex logic gates could be constructed by layering −1 PRF switches in alternative configurations within mRNAs (Supplementary Fig. 12 ).
To extend this concept to logic gates with phenotypically meaningful outputs, we designed an apoptosis module in yeast using mammalian Bcl-2 family proteins 38 . Though naturally absent from S. cerevisiae, heterologously expressed Bcl-2 family members retain their basic functions in this host 39 . Bax expression in S. cerevisiae has been shown to induce cell death through mitochondrial membrane permeabilization 40 . Moreover, coexpression of the pro-survival protein Bcl-xL protects yeast from Bax-mediated lethality 39 , consistent with its function in mammalian systems. A third subset of factors, termed the BH3-only proteins, is proposed to inhibit the pro-survival family members by direct interaction and perhaps also to activate Bax. Therefore, it has been proposed that cell fate is dictated by the relative expression of BH3-only and pro-survival proteins in a background of basal Bax expression 38 .
While previous studies in yeast have demonstrated that the BH3-only protein Puma enhances Bax-mediated lethality, coexpression of pro-survival Bcl-xL mitigated all lethal effects 41 . Thus, it is unclear to what extent Bcl-xL expression is required to rescue cells from Bax-induced cell death and how the relative production of Puma and Bcl-xL influence cell viability. Our −1 PRF expression system could offer insight into this process by precise liganddependent alteration of protein stoichiometry. We designed an expression construct that allows for the simultaneous control of the BH3-only protein Puma by a theophylline-responsive ON switch and the pro-survival protein Bcl-xL by a neomycin-responsive OFF switch (Fig. 4c) . Using the small-molecule ligands, we titrated the relative levels of Puma and Bcl-xL in a background of Bax expression and observed the effects on cell viability.
In the absence of ligands, cells were protected from Baxmediated killing through expression of Bcl-xL. Decreasing Bcl-xL npg synthesis with neomycin had only a minor effect on cell viability at maximal concentrations (fourfold decrease). Consistent with previous reports 41 , treatment with theophylline alone to increase Puma production while maintaining high Bcl-xL had no influence on Bax-mediated killing. However, when cells were treated with both ligands, we observed a cooperative effect building up to a >300-fold decrease in cell viability at maximal concentrations of theophylline and neomycin (Fig. 4c) . These results support the hypothesis that apoptosis is regulated by the relative balance between BH3-only proteins and pro-survival proteins 42 , and they establish this system as an efficient AND-gate-controlled kill switch in S. cerevisiae.
discussion
Our results demonstrate that translation reprogramming can be co-opted and engineered for the fabrication of gene regulatory devices in eukaryotes. Reprogramming mechanisms that utilize RNA are amenable to various directed evolution strategies and rational engineering with modular RNA components. Notably, our method applies a combination of these approaches to construct −1 PRF switches that control protein synthesis in yeast.
While −1 PRF switches should have utility in higher eukaryotes, it is likely that new switches will need to be fashioned based on the particular properties of the biological setting of interest. Nonetheless, our general methodological approach should be applicable to designing −1 PRF switches that are optimized for performance in mammalian cells and other eukaryotic systems where frameshifting naturally occurs. We employed an in vitro directed evolution strategy that selects for a complex functional phenotype within a cell lysate. Interestingly, some previous attempts to improve allosteric ribozymes by in vitro directed evolution resulted in devices that were nonfunctional in vivo 18 . This result was attributed to differences between the in vitro and cellular environments. However, our in vitro selections were performed within a cell lysate, enriching for a function that requires direct interaction with the cell's complex biochemical machinery. It is possible that this improved the likelihood that selection products would retain activity in vivo. Analogous to previously reported allosteric selections 17 , this mRNA display directed evolution platform might also be adapted for the selection of ligand-responsive frameshift devices or other modes of translation reprogramming.
Ligand-responsive −1 PRF switches provide distinct advantages over other gene control strategies. Since −1 PRF switches are based on modular RNA parts, it is feasible to scale the number of devices using alternative aptamer and frameshift components. The discovery of new RNA aptamers through SELEX and related approaches will be critical to this scaling effort. In comparison to other RNA devices, such as recently optimized allosteric ribozymes 16 , our first-generation −1 PRF switches demonstrate comparable fold changes in gene expression but have the benefit of regulating multi-protein-output stoichiometry. The utility of the latter feature is best highlighted by our apoptosis module, which displays a >300-fold change in cell viability using −1 PRF switches that respond to ligand with moderate five-to sixfold changes in activity. Natural biological mechanisms may utilize a similar principle of stoichiometric control that provides uniform phenotypic response across heterogeneous cell populations despite relatively small fold changes in molecular response 43 . −1 PRF switches also perform robustly in various contexts, whether independently in the setting of a fluorescent protein reporter or a transcription factor, or in conjunction with other −1 PRF switches in the context of logic gates or an apoptosis module.
While these first-generation −1 PRF switches should find broad applicability, switch performance could be improved by increasing ligand sensitivity and fold activation. The ligand detection threshold of a thermodynamically controlled RNA switch will be fundamentally limited by the binding affinity of its aptamer. However, as has occurred for many natural riboswitches, it should be possible to optimize the conversion of ligand binding energy into productive conformational rearrangements so that −1 PRF switches respond to ligand concentrations closer to the K d of their aptamers. Additionally, minimizing alternative conformations in the ON and OFF states, either through context optimization or exploration of other −1 PRF stimulatory elements, would be likely to improve the sensitivity and the dynamic range of these devices. The approaches outlined in this work, particularly the in vivo npg directed evolution strategies, establish a framework for improving −1 PRF switch performance. Overall, we believe that the tools and methodology developed here will bolster synthetic biology efforts to develop customized cellular programs and advance our capabilities to study and manipulate biological systems. Fig. 1) . This library has a theoretical diversity of 2.68 × 10 8 unique sequences. The selection construct for in vitro transcription was assembled from four oligonucleotides (AVA105, AVA106, AVA107 and AVA108) by PCR with Vent Polymerase (NEB).
In vitro selection for −1 PRF. The mRNA display protocol was carried out similar to previous reports 30, 45 . Briefly, the DNA library was in vitro transcribed with T7 RNA polymerase and purified by denaturing PAGE (8.5% Urea-PAGE). The resulting RNA was ligated to phospho-dA 27 dCdC-puromycin (TriLink Biotechnologies) by splint ligation 30 with oligonucleotide AVA95 and T4 DNA ligase. The puromycin conjugated mRNA templates were purified from non-ligated RNA by 8.5% Urea-PAGE gel. 20 pmoles (1.2 × 10 13 molecules) of mRNA display templates were translated at 30 °C for 1 h in 100 µL of 40% rabbit reticulocyte lysate (nuclease treated, Promega) supplemented with amino acids, Mg(OAc) 2 (0.5 mM final), and KCl (100 mM final). After incubation at 30 °C, the translation reaction was treated with 38 µL of puromycin salt mix (31.2 µL of 2.5 M KCl + 6.8 µL 1 M MgCl 2 ) and incubated at room temperature for 15 min, then placed on ice. mRNA-peptide fusions were FLAG purified using anti-FLAG M2 Affinity Gel (Sigma) as described 45 , then purified with Ni-NTA resin (Qiagen) as described 30 . Following purification, mRNA-peptide fusions were buffer exchanged into reverse transcription buffer using 30,000-MW cutoff spin concentrators (Amicon). cDNA was reverse transcribed from purified mRNA with Superscript II (Life Technologies) for 50 min at 42 °C (300 µL reaction containing: purified mRNA; 1 µM RT primer AVA95; 0.5 mM dNTP mix; 1X First-strand buffer; 10 mM DTT; 1 µL RNasin; 1 µL Superscript II Reverse Transcriptase). The reverse transcription reaction was spin-concentrated, then amplified with GoTaq polymerase (Promega) using primer pair AVA109·AVA108 in a 0.5 mL reaction to generate dsDNA for subsequent rounds of selection. Of note, primer AVA109 includes the entire 5′ segment of the selection construct leading up to the first in frame TAG stop codon in order to correct frameshift insertion mutations enriched in the previous round of selection.
Yeast dual-fluorescent protein reporter. The reporter plasmid was constructed by inserting the yEGFP open reading frame (amplified with primer pair AVA111·AVA112) between the GPD promoter and the open reading frame of a yeast-optimized mCherry 46 (amplified from yEmRFP) flanked by a GPD terminator in a pRS425 backbone (high copy, LEU2 marker). NheI and AatII restriction sites were encoded between the GFP and mCherry open reading frames for replacement of the intervening sequence with a −1 PRF insert. To assay library −1 PRF activity, dsDNA products from the in vitro selection were PCR amplified in two steps (primer pairs AVA117·AVA118 and AVA119·AVA118) to add homology to the NheI/AatII digested dual-FP reporter plasmid. The library was cloned by in vivo gap repair into yeast strain Fy251 using high efficiency transformation as previously described 47 and plated on selective medium (synthetic complete agar with leucine dropout containing 2% dextrose; SC-Agar-(Gluc) L). Individual colonies were isolated and grown in liquid SC-(Gluc) L-media to mid-log phase and the −1 PRF efficiency was determined by comparing quantified GFP and mCherry fluorescence signals to a fusion protein control (calibrated to 100% frameshift). For analysis of the pooled selection products, the rescued transformation was grown in liquid SC-(Gluc) L-selection media for 3 days to enrich for transformants, then analyzed directly by flow cytometry (LSRII).
NGS of in vitro selection products. NGS was performed using the Illumina HiSeq platform (Columbia Genome Center). DNA was prepared for sequencing by PCR in two separate batches containing either five or nine variable positions at the start site of the HiSeq read to avoid identical base calls during the initialization phase of sequencing. The in vitro selection products were PCR amplified with primer pair AVA317·AVA322 or AVA318·AVA322. Both PCR products were then mixed and amplified with primer pair AVA319·AVA321 to add full HiSeq adaptor sequences. After sequencing, the raw fastq file was trimmed to the scaffold of interest (see Supplementary Fig. 3) , and the copy number of each unique sequence was computed (step 1 of sequence analysis pipeline, see Supplementary Note 1).
Analysis of NGS for motif classification. The scaffold and its 14 variable positions define a restricted region of sequence space (2.68 × 10 8 ). We constructed a pseudoknot (PK) feature space based on a combination of the nucleotide constraints and our user-defined segment constraints, generating a set of 2,068 individual PK features (Supplementary Fig. 3) . We enumerated the full set of unique sequences theoretically present in the initial library and calculated their compatibilities with the 2,068 PK features. The feature with the greatest amount of base pairing (including G·U) was associated to each sequence. PK compatibilities were similarly calculated for the sequences observed in the in vitro selection products. Highly enriched PK features could then be measured by comparing the two distributions. Of the top 10% of PK features by enrichment, those with the highest absolute representation in the selection library defined the broad motif categories. Within a set of PK-compatible sequences, a greedy clustering algorithm was used to divide the set of sequences into the final motifs. The modes of the different motif sets were further characterized in terms of the abundances and entropies of their immediate neighborhood in sequence space. In particular, the modes from the highest abundance motifs were assessed for single-nucleotide and pairwise nucleotide variant sensitivity to reveal potential base pair position and tertiary interactions within a given PK geometry. See Supplementary Note 1 for further details, and Supplementary Data 1 for the motif table.
Rational design and in vivo characterization of −1 PRF switches. Switch constructs were evaluated using RNA secondary structure predictions and thermodynamic calculations (NUPACK and pKiss) as described in Supplementary Note 2, Supplementary 
